z-logo
Premium
Accumulation of CCR4‐expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia
Author(s) -
Katoh S.,
Fukushima K.,
Matsumoto N.,
Matsumoto K.,
Abe K.,
Onai N.,
Matsushima K.,
Matsukura S.
Publication year - 2003
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1034/j.1398-9995.2003.00149.x
Subject(s) - ccr4 , bronchoalveolar lavage , cc chemokine receptors , chemokine , eosinophilic pneumonia , ccl17 , immunology , medicine , flow cytometry , eosinophil , chemokine receptor , microbiology and biotechnology , chemistry , lung , inflammation , asthma , biology
Background: Th2 cells are thought to be involved in eosinophilic inflammation of the lung. CC chemokine receptor 4 (CCR4) has been identified as a specific receptor for both thymus and activation‐regulated chemokine (TARC) and macrophage‐derived chemokine (MDC), and is preferentially expressed on Th2 cells. Objective: Our aim was to evaluate the role of Th2 cells in the lung of patients with eosinophilic pneumonia (EP). Methods: The concentrations of TARC, MDC, and interleukin (IL)‐5 were measured in bronchoalveolar lavage fluid (BALF) by ELISA. Proportion of CCR4‐expressing CD4+ T cells (CCR4+ CD4+ T cells) was determined by flow cytometry. Results: TARC and MDC concentrations in BALF were higher in patients with EP than in normal subjects. The proportion of CCR4‐expressing cells among CD4+ T cells was higher in BALF than in peripheral blood of patients with EP. There was a significant correlation between the number of CCR4+ CD4+ T cells and the levels of TARC, MDC, and IL‐5 in BALF of patients with EP. Conclusions: Our data suggest that Th2 cells, which express CCR4 and its ligands (TARC and MDC), contribute to the pathogenesis of EP in the lung.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here